Immunologix Laboratories Appoints Dr. Corinna Fiorotti As Chief Commercial Officer (CCO)
Immunologix Laboratories announced today that Dr. Corinna Fiorotti has been appointed Chief Commercial Officer.
Dr. Fiorotti holds a Ph.D. in Microbiology and Immunology and has worked in drug development for 19 years, with combined experience from both Sponsor and CRO organizations. She brings a comprehensive perspective to the business development endeavors at Immunologix and is uniquely positioned to serve as CCO.
"We are fortunate to have someone of Dr. Fiorotti's caliber and experience step up to lead the commercial operation, including the business development team, at Immunologix" said Michael Anderson, President and CEO. "Corinna is strategically positioned for the role of CCO as she has a deep understanding of our business from both the scientific and business points of view and brings a strong track record of business success. As a member of our unique Translational Sciences team at Immunologix for the past 2 years, Dr. Fiorotti has built an in-depth understanding of our services and the market. She is a strong communicator who is customer focused and possesses operational and leadership capabilities to successfully execute on the company's strategy and growth plans"
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
